Delayed Intensification Including Venetoclax and Bortezomib Prolongs Survival in Very High Risk Acute Lymphoblastic LeukaemiaJasmeet Sidhu, Shekhar Krishnan, Parag Das et al.|Blood|2023Cited by 1